Tier 1 — highest

Differential effects of vitamin D2 and D3 supplements on 25-hydroxyvitamin D level are dose, sex, and time dependent: a randomized controlled trial

Muhammad M Hammami, Ahmed Yusuf
BMC endocrine disorders 2017 17(1):12

Bibliography

PubMed
PMID 28231782
PubMed Central
PMC5324269
Trial registry
View on ClinicalTrials.gov Registered trial — results not yet published in a peer-reviewed journal.
Funding
Support is recorded from King Abdul-Aziz City for Science and Technology. See the original publication for grant and material-support details.
Competing interests
The authors report no relevant competing interests.

Study snapshot

DesignRandomized controlled clinical trial
ModelHuman participants
Sample279 adults randomized; 269 contributed analyzable results
InterventionD2, D3, their combination or placebo with daily and intermittent schedules
Duration140 days
EndpointsVitamin D-metabolite exposure; Effects of schedule and sex

What the study showed, in plain terms

This publication examines vitamin d-metabolite exposure, effects of schedule and sex. Study population or evidence base: 279 adults randomized; 269 contributed analyzable results. Intervention or exposure: D2, D3, their combination or placebo with daily and intermittent schedules.

Key findings

Both forms raised vitamin D status, but responses depended on dosing schedule, baseline status and sex. D2 supplementation also lowered circulating 25(OH)D3 in some comparisons.

What this study can and cannot tell us

Multiple dosing arms and biochemical endpoints. The results do not define a universally superior schedule or a clinical-outcome difference.

Editorial review

Reviewed by the Biohack Blueprint research team

Last verified

Biohack Blueprint Research